Human microvascular endothelial cells express receptors for platelet-derived growth factor
- PMID: 1848018
- PMCID: PMC51158
- DOI: 10.1073/pnas.88.5.2021
Human microvascular endothelial cells express receptors for platelet-derived growth factor
Abstract
Endothelial cells have been widely thought to be unresponsive to platelet-derived growth factor (PDGF, a major growth factor released from stimulated platelets at the sites of vascular insults) and devoid of PDGF receptors. Nevertheless, in examining the growth-factor responses of microvascular endothelial cells isolated from human omental adipose tissue, we were surprised to detect PDGF-induced tyrosine phosphorylation of a 180-kDa glycoprotein, subsequently identified as the cellular receptor for PDGF by specific immunoprecipitation. Scatchard analysis of 125I-labeled PDGF binding to human microvascular endothelial cells revealed 30,000 PDGF receptors per cell with a Kd of 0.14 nM. PDGF stimulated tyrosine phosphorylation of PDGF receptors and other cellular proteins in a dose- and time-dependent manner, with half-maximal receptor phosphorylation occurring at 0.3 nM recombinant human PDGF (B chain) and a less than or equal to 1-min exposure to PDGF. Normal cellular consequences of receptor activation were also observed, including tyrosine phosphorylation of a 42-kDa protein and serine phosphorylation of ribosomal protein S6. Furthermore, PDGF was mitogenic for these cells. Microvascular endothelial cells play a central role in neovascularization required for wound healing and solid tumor growth. Thus, the discovery of functional PDGF receptors on human microvascular endothelial cells suggests a direct role for PDGF in this process.
Similar articles
-
Receptors for platelet-derived growth factor on microvascular endothelial cells.EXS. 1992;61:85-90. doi: 10.1007/978-3-0348-7001-6_15. EXS. 1992. PMID: 1319780
-
Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis.J Clin Invest. 1994 Jan;93(1):131-9. doi: 10.1172/JCI116936. J Clin Invest. 1994. PMID: 7506710 Free PMC article.
-
Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels.J Cell Physiol. 1989 Jun;139(3):509-16. doi: 10.1002/jcp.1041390309. J Cell Physiol. 1989. PMID: 2472412
-
Platelet-derived growth factor: mechanism of action and relation to oncogenes.J Cell Sci Suppl. 1985;3:65-76. doi: 10.1242/jcs.1985.supplement_3.7. J Cell Sci Suppl. 1985. PMID: 3011826 Review.
-
Platelet-derived growth factor.Clin Endocrinol Metab. 1984 Mar;13(1):191-205. doi: 10.1016/s0300-595x(84)80013-4. Clin Endocrinol Metab. 1984. PMID: 6327124 Review.
Cited by
-
Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.Am J Pathol. 2006 Nov;169(5):1767-83. doi: 10.2353/ajpath.2006.060120. Am J Pathol. 2006. PMID: 17071599 Free PMC article.
-
Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC.Onco Targets Ther. 2011;4:43-58. doi: 10.2147/OTT.S18155. Epub 2011 May 30. Onco Targets Ther. 2011. PMID: 21691577 Free PMC article.
-
Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects.J Mol Med (Berl). 1995 Jul;73(7):333-46. doi: 10.1007/BF00192885. J Mol Med (Berl). 1995. PMID: 8520966 Review.
-
Platelet-derived growth factor indirectly stimulates angiogenesis in vitro.Am J Pathol. 1993 Apr;142(4):1119-30. Am J Pathol. 1993. PMID: 7682762 Free PMC article.
-
Identification of Blood Circular RNAs as Potential Biomarkers for Acute Ischemic Stroke.Front Neurosci. 2020 Feb 6;14:81. doi: 10.3389/fnins.2020.00081. eCollection 2020. Front Neurosci. 2020. PMID: 32116524 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources